WHO ICTRP trial
Studying Conditioning Regimen In Pediatric Transplantation – AML
EUCTR2021-003282-36-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-003282-36-SE |
|---|---|
| Public title | Studying Conditioning Regimen In Pediatric Transplantation – AML |
| Scientific title | A Randomized, Multi-Center Phase III Trial comparing two conditioning regimens (CloFluBu and BuCyMel) in children with Acute Myeloid Leukemia undergoing allogeneic stem cell transplantation. - SCRIPT-AML |
| Primary sponsor | Västra Götalands Regionen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Sweden;Netherlands;Hong Kong;Belgium;Norway;Finland;Denmark;Israel;Lithuania;Spain |
| Conditions | Acute myeloid leukemia (AML) in children;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] |
| Interventions | Trade Name: Busilvex Pharmaceutical Form: Concentrate for dispersion for infusion Product Name: Cyclophosphamide Pharmaceutical Form: Powder for solution for infusion INN or Proposed INN: CYCLOPHOSPHAMIDE CAS Number: 50-18-0 Product Name… |
| Registration date | Jul 9, 2021 |
| Target size | 230 |
| Secondary IDs | 123123 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: